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1. Introduction 
Tight junctions are cellular structures present in epithelial, endothelial and mesothelial cells 
(1, 2, 3). They are located at the apicolateral part of the cell membrane and regulate the 
paracellular permeability of cell layers which is called the gate function (4). They also have a 
fence function segregating the apical region of the cell membrane from the lateral parts 
preventing proteins of the apical area from mixing up with those of the lateral regions (1,4). 
Tight junctions also take part in determination of cellular polarity (1,4). They prevent 
pathogens from invading into the subepithelial tissues and thus can be considered to 
represent one part of the innate immune system (5).  
In freeze fraction electron microscopy tight junctions form a beltlike branching structure 
around the cell which varies from 0.27m to 0.37m in thickness which depends on the cell 
type (6). Tight junctions are composed of membrane proteins and scaffolding proteins.The 
former include claudins, occludin, tricellulin and junctional adhesion molecules (7). 
Claudins, occluding and tricellulin have four transmembrane domains while junctional 
adhesion molecules have only one (7). Scaffolding proteins mediate interactions between 
tight junctions and the interior compartments of the cells. They include ZO-1 (Zona 
occludens-1), ZO-2, ZO-3, MAGI-1 (membrane-associated guanylate kinase with inverted 
orientation-1), cingulin and MUPP1 (multi-PDZ domain protein 1) (1,7).  
2. Claudins 
Claudins are tight junction proteins responsible for the regulation of paracellular 
permeability in cell layers. There are 27 claudins known and the diversity of claudins is the 
basis for differences in the solute and electrical permeability in different cell layers (1,8) 
(Table 1). In kidney tubules different claudins are expressed in different areas of the 
nephron determining the solute and electrolytic permeability in different regions of the 
kidney tubule (9). A similar segmental distribution in claudin expression is observed in the 
gut (10). Claudins do not share structural resemblance to either occludin or tricellulin (11). 
Claudins are key components of tight junctions (1,4). They are 21-28kDa proteins containing 
an aminoterminal intracellular part, four transmembrane domains, two extracellular loops, 
an intracellular loop and an intracellular carboxyterminal end (1,4,5,7). The carboxyterminal  
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Claudin 
Chromosomal 
location 
Molecular 
weight (kDa) 
Mutations/ 
disease 
Splice 
variants
Other aspects 
CLD1 3q28-29 22.7 
Ictyosis, 
Sclerosing 
cholangitis 
 
Entry cofactor for hepatitis C 
virus, right-left patterning in 
embryogenesis, knockdown 
causes transdermal water loss 
CLD2 Xq22.3-q23 24.5 - 5 
Knockdown prevents bile 
canalicular formation  
CLD3 7q11.23 23.3   Receptor for CPE 
CLD4 7q11.23 22.0   Receptor for CPE 
CLD5 22q11.21 23.1   
Present mainly in 
endothelium, heart 
development in Xenopus, 
knockdown causes 
disturbances in BBB function 
CLD6 16p13.3 23.3   
Entry cofactor for hepatitis C 
virus 
CLD7 17 22.4  3 
Knockdown decreases Cloride 
permeability 
CLD8 21.22.11 24.8    
CLD9 16p13.3 22.8   
Entry cofactor for hepatitis C 
virus 
CLD10 13q31-34 24.2-24.5  6  
CLD11 3q26.2-q26.3 21.9 
Deafness, 
Sertoli cell 
dysfunction 
 
Knockdown causes nerve 
conduction disturbances, male 
sterility, deafness 
CLD12 7q21 27.1  3 
D vitamin induced Ca 
abrorption from enterocytes 
CLD14 21q22.3 25.7 
Sensoryneural 
deafness 
5 
Reduced mineral bone density, 
kidney stones, 
knockout causes deafness 
CLD15 7q11.22 24.3  2 
Megaintestine in knockout 
mice 
CLD16 3q28 33.8 
Hypomagnese
mia type 3 
  
CLD17 21q22.11 24.6   Intronless gene 
CLD18 3q22.3 27.7-27.9  2 
Present in lung, 
gastrointestinal tract 
CLD19 1p34.2 22.0-23.2 
Hypomagnese
mia with ocular 
involvement 
2 
Knockout affects nerve 
conduction 
CLD20 6q25 23.5    
CLD21 4q35.1 25.4    
CLD22 4q35.1 25.5   Intronless gene 
CLD23 8p23.1 31.9   
Expressed in germinal center B 
cells, stomach, placenta 
CLD24 4q35.1 22.8    
CLD25 11q23.2     
Claudins 13, 26 and 27 are not found in humans 
Table 1. Some characteristics of different claudins present in humans 
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end contains the PDZ domains by which scaffolding proteins like ZO1 and ZO2 attach to 
claudins (1, 12). The larger of the extracellular loops (EL1) influences paracellular charge 
selectivity and contains the co-receptor site for Hepatitis C virus (HCV) (1,12). The smaller 
loop (EL2) mediates attachment of the claudin molecule to the corresponding one of the 
neighbouring cell and also contains the oligomerisation site and receptor site for clostridium 
perfringens enterotoxin (CPE) (1,12) (Figure 1). 
The larger loop (EL-1) regulates paracellular electrical and solute permeability. The smaller 
loop (EL-2) mediates attachment between claudins of different cells. Four transmembrane 
domains separate the ends of the loops from the intracellular sequences of the molecules. 
The intracellular carboxyterminal end contains attachment sites for the PDZ domains of ZO-
1, ZO-2 and ZO-3 molecules. It also contains phosphorylation sites which influence the 
function of claudins. 
 
 
 
 
 
 
 
 
Fig. 1. A schematic presentation of the general molecular structure of claudins. Claudins 
form a structure formed by two extracellular loops (EL-1 and EL-2) in the cell membrane. 
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Claudins may associate with each other as homodimers or heterodimers (1). 
Heterodimerisation occurs selectively between specific claudins, for example, Claudins 1 
can heterodimerise with 4 but not with 2 (1). In addition to such vertical association between 
neigbouring cells, claudins also bind to one another laterally on cell membranes to form the 
tight junctional strand (1). Claudin 2 expression in tight junctions generally leads to a leakier 
barrier function (1).Generally, claudins 2, 7, 10, 15 and 16 increase paracellular cation 
permeability by forming pores in the tight junctions whereas claudins 4, 5, 8, 11, 14 and 18 
have an opposite function (1). 
Claudins are widely expressed in epithelial cells but they are also found in endothelial and 
mesothelial cells, and in glial cells (2, 3, 13, 14). Several types of claudins are expressed in 
epithelial cells, but their distribution may vary according to the cell type and tissue site in 
question (2). Some claudins have a characteristic distribution. Claudin 5 is found in 
endothelial cells but it is also found in epithelium especially in neoplasia (1, 2). Claudin 11 is 
found in oligodendrocytes and in Sertoli cells but its expression has also been shown in 
endothelial cells of the corpus cavernosus (15, 16). 
2.1 Claudins in disease 
Claudin expression is modified in many diseases including both neoplastic and non-
neoplastic conditions (5, 17). In cancers derived from epithelial cells claudin expression may 
be increased or decreased (17).The expression of claudins varies in tumors at different sites 
(7) and is different in head and neck (18), pancreatic (19), colonic (20,21), ovarian (22), and 
breast cancers (23) as well as within the same site like in gastric cancer, where there is lower 
expression of claudins in diffuse carcinoma compared to the intestinal type (24). In breast 
cancer claudin 4 expression is increased and its expression is found in more aggressive types 
of tumors (25). Claudin 16 expression, on the other hand, is associated with a better 
prognosis (26). Moreover, claudin 7 is downregulated in many cancers, such as breast and 
colon carcinoma, where its diminished expression is also associated with a poor prognosis 
(21, 27).  
In non-epithelial cancers, claudin expression has been found in malignant mesotheliomas, 
tumors derived from cells lining serosal cavities (3). The expression of claudins is, however, 
lower than that found in epithelial tumors and the difference in claudin expression can be 
used in the differential diagnosis between mesotheliomas and adenocarcinomas metastatic 
to the lung (3). Such findings have been substantiated in many reports indicating that 
claudin 3 and 4 might be especially useful in this respect (3, 28). 
Claudins may also be useful in the differential diagnosis between soft tissue tumors and 
carcinomas, especially when such tumors are poorly differentiated and their origin is hard 
to substantiate based on morphology alone. Soft tissue tumors generally do not express 
claudins, exceptions are synovial sarcomas which also morphologically contain epithelial 
elements, and perineurinomas (29, 30). Furthermore, hemangiomas and angiosarcomas 
express claudin 5, by which expression they can be distinguished from other soft tissue 
tumors (2). 
In non-neoplastic diseases claudin expression may be deranged in diseases where the 
permeability of cell layers is disturbed. Such conditions include intestinal and kidney 
diseases, vascular diseases and lung diseases with a diminished or lost cellular permeability 
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leading to tissue edema. In various inflammations, claudin expression may be deranged. 
Examples of such are chronic colitis, like Crohn’s disease or colitis ulcerosa where 
expression of claudins have been changed (31,32). Many intestinal pathogens, such as 
aggressive strains of E coli, may lower the electrical and solute permeability of intestinal 
epithelia through displacement or downregulation of claudins and tight junctional 
scaffolding proteins leading to loss of fluid to the intestinal lumen (33,34). Claudins may 
also serve as receptors for bacterial toxins and viruses. Claudin 1 serves as a coreceptor for 
hepatitis virus 1, and several viruses may modify tight junctional permeability by 
downregulation or displacement of claudins from the tight junction (35, 36, 37, 38). Also 
bacterial toxins may use claudins as receptors. The toxin secreted by clostridium perfringens 
uses claudin 3 and 4 as receptors to open up paracellular spaces between cells (39). This also 
leads to cellular destruction and clostridium perfringens enterotoxins has been used in 
experimental models as a chemical to destroy ovarian and prostate cancer cells which have a 
high expression of claudins 3 and 4 (39). Additionally, modified clostridium perfringens 
enterotoxin (CPE) can be used in treatment of cancer to enable penetration of cytostatic 
drugs to cancer tissues (5, 39). 
In the kidney, claudins are differentially expressed along the tubular segments leading to a 
modulated anionic and solute permeability in different regions of the segments which is 
detrimental for the absorption functions of the kidney (9). Claudins 16 and 19, for instance, 
regulate Mg and Cl permeability of the kidney tubular cells and mutations in these claudins 
lead to disturbances of the permeability of these electrolytes (40). In lung diseases like 
ARDS, expression of claudin 4 is downregulated leading to increased permeability of the 
alveolar wall (41, 42). Counteracting claudin 4 downregulation could thus be one putative 
treatment for this often fatal lung disease. 
2.2 Claudins in gonadal structures 
In mRNA and array analysis indicate that claudins 1, 2, 3, 5, 7, 8, 10, 11, 12, and 23 are 
present in testicular tissue of rodents. Claudin 11 is found to be the highest (15). Such 
studies do not, however, indicate the location of claudin mRNA, and claudin 5 mRNA, for 
instance, may also partly be derived from endothelial cells. 
In human testicular tissues claudin 1, 6 and 7 protein expression has been found in 
seminiferous tubules (43). In rete testis epithelium, claudins 1 and 7 are strongly expressed 
while claudin 4 is weak and claudins 3, 5 and 6 are negative (43). Claudin 11 is present in 
Sertoli cells and takes part in formation of the blood testis barrier (44). In normal 
seminiferous epithelium claudin 11 is located at the basal compartment and the distribution 
is similar to ZO1 and ZO2 in this location (45). Claudin 1, 3 and 11 expression in Sertoli cells 
of mouse and rat testis appears to be regulated by androgens (46, 47, 48). Also 
gonadotropins regulate the expression of tight junctional proteins such as claudin 11 and 
occludin (49). 
Expression of claudins and other tight junction proteins have not been studied in ovaries to 
such an extent as in the testis. Trace amounts of claudin 1, 2 , 4, 5, 7, 10, 11, 12 have been 
detected in normal ovarian tissues (17). Ovarian surface epithelial cells express claudin 1, 
ZO1 and occludin (50). Ovarian HOSE (human ovarian surface epithelial) cells do not 
express claudins 3 or 4 (51). On the other hand, in array based analysis, ovarian serous 
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cancer cells displayed a strong mRNA expression of claudins 3, 4 and 7 compared  
to non-neoplastic cells (52).Claudin 3 and 4 expression appears to be nonexistent in surface 
ovarian cells but is increased in ovarian cysts (53).  
3. Germ cell tumors 
Germ cell tumors represent a tumor group derived from primordial germ cells of the body 
(54). They develop in testicular and ovarial tissues but are also found at extragonadal sites 
such as the mediastinum, and hypothalamic or suprasellar regions. Up to 95 % of testicular 
tumors are of germ cell derivation while in ovaries they make up only of 3-5 % of the tumor 
cases (55). Germ cell tumors of the testis develop from intratubular germ cell neoplasia 
(ITGCN) (except for spermatocytic seminoma and infantile germ cell tumors) and their 
development is linked to maturation arrest.The corresponding ovarian counterpart for 
ITGCN is gonadoblastoma (56). 
Germ cell tumors can be divided in pure and mixed form (54). Pure germ cell tumors are 
composed of only one tumor component while mixed tumors consist of two or more (54). 
Testicular mixed germ cell tumors represent 30 to 50 % of the tumors while in the ovaries 
they represent about 20 %. The commonest pure germ cell tumor is 
seminoma/dysgerminoma representing 50 % and 40 % of testicular and ovarian germ cell 
tumors, respectively. Embryonal carcinoma is composed of undifferentiated cells with an 
epithelial appearance and it is more common in testis than in ovaries (54,57). Yolk sac 
tumor, on the other hand, is relatively more common in the ovaries (57). There are many 
histologic patterns, such as microcystic, papillary, macrocystic, hepatoid, solid and 
glandular-alveolar patterns, often mixed with each other (54). The tumor recapitulates the 
structures of yolk sac, the allantoin membrane and extraembryonic mesenchyme (54). It 
contains hyaline globules and Schiller-Duval bodies (57). Choriocarcinoma is rare both in 
ovaries and testis (54). It is composed of neoplastic cytotrophoblastic and 
syncytiotrophoblastic cells intermixed with hemorrhagic and necrotic background (54). 
Examples of benign germ cell tumors are teratomas which display a mixture of mature 
endodermal, mesodermal or ectodermal components (54). In some teratomas one 
component may predominate. Such is the case in dermoid cysts which contain a 
predominant component of cutaneous tissue leading to a cystic tumor containing keratin 
and hair structures (58). In immature teratomas or teratomas with somite type malignancies 
one or more components of the cell layers is malignant (54). 
Immunohistochemical markers useful in the diagnosis of germ cell tumors include AFP and 
HCG which are positive in yolk sac tumor and choriocarcinoma, respectively (54,59). PLAP 
is invariably present in both but also in seminoma and embryonal carcinoma (54,59). They 
both express OCT3/4 which is not present in yolk sac tumor or choriocarcinoma (54,59). 
Embryonal carcinoma expresses SOX2 and CD30 which are not present in seminoma which, 
on the other hand, expresses SOX 17 (54,59). 
4. Claudins in germ cell tumors 
Germ cell tumors are neoplasms which are derived and may express several cell types of the 
ectoderm, endoderm or mesoderm. There are also many times a mixture of different cell 
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components in these tumors (54). Of benign germ cell tumors a good example is teratoma 
which contains full developed components of epithelial, mesodermal and/or neural 
elements (54,58). Claudin expression in these tumors is analogous to the expression found in 
tissues of the comparable non-neoplastic tissues in human body (43). Thus expression of 
claudins 1, 2, 3, 4, 5 and 7 is usually amply found but expression is different in squamous or 
glandular epithelia (43). Squamous epithelium expresses strongly claudin 1 and 4 but 
claudin 3 is weakly or negatively expressed (43). On the other hand, glandular epithelia 
express claudin 3 strongly in teratomas (43). Claudin 7 is strongly expressed in both of these 
epithelia, but claudin 5 and 6 are negative (43). The different expression of claudins 3 and 4 
is also reflected in malignant tumors derived from squamous or glandular epithelia. 
Adenocarcinomas of the oesophagus show a significantly higher expression of claudin 3 
than squamous cell carcinomas (60). A similar situation is found for between lung squamous 
cell and adenocarcinomas (61). Mesenchymal tissues are generally negative for claudins 
with the exception of claudin 5 which is expressed in endothelial cells (2). Blood vessels may 
also show expression of some other claudins, like claudins 2 and 3 (2). Tissues found in 
teratomas are, however, many and strong conclusions cannot be drawn based on materials 
consisting only of some cases. 
Teratocarcinomas express variable levels of claudins 1, 2, 3, 4 and 7 in carcinomatous 
elements but some cases display also positivity for claudins 5 and 6 (43). Claudin 5 which is 
mainly an endothelial marker and partly responsible for the function of blood brain or blood 
testis barrier (15, 62) is overexpressed in several carcinomas, like ovarian or lung carcinomas 
(61, 63, 64). The expression appears to be present in poorly differentiated tumors in serous 
ovarian carcinomas and is associated with a worse survival (64). Such expression may reflect 
a more primitive nature of the epithelial tumor cells but may also be an expression of 
vascular mimicry in tumors reflecting the capacity of neoplastic epithelial cells to attain 
endothelial features, a phenomenon described in melanomas, sarcomas and carcinomas 
(65,66). Whether expression of claudin 5 in teratocarcinomas influences behavior of these 
tumors is, however, unknown. 
In tumor biology, derivation of malignant tumors has been suggested, on one hand, to 
clonal evolution of malignant cells, on the other hand, tumors have been suggested to 
develop through stem cells (67, 68). In clonal evolution there is a constant development of 
varied population of malignant cells and the most apt ones having the best survival 
capabilities to survive and make up the bulk of the tumors and develop metastases (67,68). 
According to the stem cell theory, tumors contain a population of stem cells which are 
present in specific locations (niche) in tumors (68). These cells which produce cancer tissue 
through dysregulation of asymmetric division are the basic invasive and metastasizing 
elements of the tumor and the rest are a more differentiated bulk which have not a 
significant impact on the spread and survival of the cells (68). Primitive pluripotent stem 
cells do not usually express antigens. Organ specific stem cells already committed to a 
specific differentiation can, however, be characterized by specific antigens (69). Such 
antigens present in breast carcinomas are CD44 and CD25, for instance (69). Of claudins, 
claudin 6 has been suggested to be an early epithelial stem cell marker (70). In line with this 
claudin 6 was present in a proportion of epithelial elements of teratocarcinomas, and in 
embryonal carcinomas but also in yolk sac or choriocarcinomatous elements suggesting that 
such claudin 6 positive stem cell may also differentiate towards extraembryonic cells (43).  
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Generally, however, claudins are parts of an element which is a sign of differentiation in 
epithelia, and their presence on the cell membrane of epithelia speaks for the presence of 
functioning tight junctions (1,2). Thus, a feature expected for a stem cells could be a lack of 
claudin expression. Indeed, in breast carcinoma, a claudin low population of breast 
carcinomas, having a low expression of claudins 3, 4 and 7 has been characterized to 
represent a tumor with similar features to the triple negative breast tumors and having a 
significant overlap with them (71). Even though there is a diminished expression of claudin 
3 and 4 in embryonal carcinoma and claudin 3 in teratocarcinoma, both tumors express 
strongly claudin 7 and generally express claudins 1-7. The concept of stem cells cannot thus 
be addressed through diminished or absent claudin expression in germ cell tumors.  
Embryonal carcinomas are primitive tumors committed to the epithelial lineage. In line with 
this they express claudins 1-7 (43). There is only one study which has investigated claudin 
expression in these tumors, but work has also been carried out in embryonal carcinoma cell 
lines. In the studies of Sawada et al, the F9 embryonal carcinoma cell line expressed the 
studied claudins 6 and 7 and this expression was induced by hepatocyte nuclear factor 
alpha (72). It also induced the formation of tight junctions and a polarised morphology of 
these cells and retarded cellular proliferation by upregulation p21 (72). Differentiation of 
embryonal cells to embryoid bodies increase the mRNA of several claudins, such as claudins 
2, 6 and 7 and also occludin (73). 
Seminomas are primitive germ cell tumors which have a specific morphology consisting of 
nests of large round cells which are usually surrounded by an inflammatory infiltrate 
consisting of small lymphocytes (54). Seminomas express strongly claudin 7 but some cases 
express also claudin 5 (43). The specific expression of these claudins in seminomas with lack 
of claudins 3, 4 and 1 clearly distinguishes these tumors from other germ cell tumors (43). 
Seminomas also display a strong expression of twist suggesting that it might be one factor 
contributing to the lack of expression of these claudins (43). Twist expression is associated 
with a poor prognosis in some tumors, such as breast carcinoma, but generally the 
expression of twist is low in carcinomas (74). It, however, is supposed to contribute to 
epitheliomesenchymal transition (EMT) in organ specific tumors which is also in line with 
the association with this function (74). A high expression of twist in seminomas probably 
signifies an inherent character of these tumor cells to express this transcription factor and it 
probably has another function in such a non-epithelial neoplasm. There are, however, no 
clinical studies assessing the prognostic value of twist or claudins in seminoma or other 
germ cell tumors. 
Choriocarcinomas are aggressive tumors differentiating towards trophoblastic cells (54). 
Areas of choriocarcinoma are many times present in mixed germ cell tumors and pure 
choriocarcinomas are rare (54). They consist of large, neoplastic trophoblastic cells with 
areas of strong hemorrhage (54). Choriocarcinoma cells have an especially strong expression 
of claudin 4 (43). Claudin 4 is commonly present in epithelial neoplasms and in several 
tissues and it is considered to have a sealing function on paracellular membranes (1). In lung 
diseases, for instance, claudin 4 is downregulated in acute respiratory distress syndrome 
and lung inflammations contributing to the development of lung edema (41,42). Claudin 4 
also serves as a receptor for clostridium perfringens enterotoxin, and chemically modified 
enterotoxins have been used in cancer treatment to facilitate penetration of 
chemotherapeutics to claudin 4 positive tumors (39). The significance of the strong 
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expression of claudin 4 in choriocarcinoma cells is obscure but suggests that its expression 
may be important for the function of trophoblastic cells.  
Intratubular germ cell neoplasia is the precursor lesion of germ cell neoplasms of the testis 
(54). In studies on claudin 11 expression in these lesions, claudin 11 expression was 
increased but the increased did not take place in the neoplastic germ cells but in Sertoli cells 
where claudin 11 was displaced from the membrane (45). The relative protein expression of 
claudins 1-7 in testicular germ cell neoplasia and testicular tissue is presented in Table 2 (43). 
 
Germ cell tumor 
component 
claudin 1 claudin 3 claudin 4 claudin 5 claudin 6 claudin 7  
seminoma - - - ++ - ++  
embryonal carcinoma ++ + + ++ ++ +++  
teratocarcinoma +++ + +++ ++ ++ +++  
teratoma +++ ++ +++ ++ ++ +++  
chorioncarcinoma - - ++ + + +  
Testicular tissue        
seminiferous tubules + - - - + +  
Rete testis epithelium +++ - + - - +++  
-=negative; += weak, ++= moderate, +++= strong expression 
Table 2. Summary of the average protein expression of claudins 1, 3, 4, 5, 6 and 7 in germ 
cell tumors and testicular tissues 
5. Claudins in diagnosis and treatment of germ cell tumors 
Seminomas differ from other germ cell tumors by their expression of claudin 5 and 7 and 
lack of other claudins (43). Choriocarcinoma, on the other hand, expresses claudin 4 strongly 
(43). However, germ cell tumors have a specific histopathologic character and many times it 
is easy to distinguish seminoma or chorioncarcinoma from other germ cell tumors. In lymph 
node metastases, analysis of claudins might be of some help. Seminomas in lymphatic 
tissues in the mediastinum, for instance, may resemble the syncytial variant of nodular 
sclerosis Hodgkin’s disease which do not express claudins at all (2). Germ cell tumors, 
however, have already established markers and claudins may hardly will be of any 
additional help in their diagnosis (54). 
Claudins 3 and 4 have been found to function as receptors for clostridium perfringens 
enterotoxin (CPE) (39). In prostate and ovarian cancer cell lines expressing claudins 3 and 4 
clostridium perfringens enterotoxin is able to destroy such cells (75,76). Claudins 3 and 4 
are, however, expressed in many non-neoplastic cells so CPE cannot be used in treatment of 
cancer without side effects even though the cytotoxicity appears to be lower in non-
neoplastic cells (76). Chemically modified CPE has, however, been used to open up tight 
junctions in cancer treatment experiments to allow a better penetrance of chemotherapeutic 
drugs to reach cancer cells (77). Such treatments strategy might also be possible in 
intratubular germ cell neoplasia when the tumor cells are still enveloped by the blood testis 
barrier. The main claudin responsible for the tight junctional permeability in the blood testis 
barrier is claudin 11, although claudins 3 and 5 also play some role (15). Additionally, CPE 
treatment based on cytotoxicity might be theoretically possible in those cases of germ cell 
neoplasia expressing claudins 3 and 4, like chorioncarcinoma or embryonal carcinoma (43).  
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5.1 Claudins in Sertoli cells 
The blood testis barrier is formed by tight junctions between adjacent Sertoli cells (15). Claudin 
11 is obligatory for the function and formation of tight junctional barrier in the testis (15). In 
claudin 11 knockout mice, Sertoli cells are detached from the seminiferous tubules and attain 
fibroblastoid features (78). In androgen receptor depleted mice the development of tight 
junctions of Sertoli cells is deranged with aberrations in the expression of several genes 
including occludin, claudin 11 and 3 (79, 80). Additionally, also claudin 5 mRNA has been 
detected in seminiferous epithelial cells and its expression is increased in mice at the time of 
blood testis barrier development (15). The expression of claudin 5 was dependent on ets 
variant gene 5 (ETV5) and germ cells (15). Interestingly, claudin 5 was not affected by ETV5 in 
vascular structures of the testis (15). The loss of claudin 5 expression in Sertoli cells resulted in 
an elevated solute permeability as detected by biotin tracer leakage (15). 
TGFbeta3 inhibits the expression of claudin 11, occludin and ZO1 by a MAP 38 kinase 
dependent mechanism in Sertoli cells (81). FSH and TNF alpha inhibits claudin 11 
expression in Sertoli cell culture (82). Testosterone increases claudin 11 mRNA expression in 
a dose dependent manner (47). The influence of antiandrogenic flutamide is complex (47). 
Fetally administered flutamide in mice resulted in prepubertal decrease of claudin 11 in 
Sertoli cells but the inhibition in adult testes was dose dependent, lower doses resulting in 
decreased expression (47). When given orally to 13 weeks’ old rats, flutamide induced a 
decrease in the mRNA expression of occludin but did not affect claudin 1 or 11 mRNA (83). 
Thus androgens and gonadotropins may theoretically influence the penetrance of the blood 
testis barrier by modifying claudin 11 expression but such treatment strategy may lead to 
intolerable side effects perhaps through breakage of self tolerance and development of 
autoimmune diseases or reactions induced by exposure of self antigens normally hidden by 
the blood testis barrier. 
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